Skip to content
healthcare.dev
Get a free key

Terazosin

NDC 62135-459, Terazosin, capsule, from Chartwell RX, LLC.

Product NDC
62135-459
Status
Listed
Labeler
Chartwell RX, LLC
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA075614
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62135-459 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TERAZOSIN HYDROCHLORIDE2 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
62135-459-906213504599090 CAPSULE in 1 BOTTLE (62135-459-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/da4ca0f8-6888-447e-9948-d37196c5a19a

  • NADAC price for package 62135045990

    GET /v1/drugs/nadac/62135045990

Use it

Look up 62135-459 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62135-459 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62135-459. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.